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Abstract 
Background: Recently, new carbapenemases in Enterobacteriaceae strains and non-fermentative gram-negative 
bacilli have been reported. The New Delhi metallo‐β‐lactamase-1 (NDM-1) is a major problem around the world. The 
purpose of this article is to address the NDM-1 Klebsiella pneumoniae epidemic detected in eight cases in our hospital.
Methods: Bacteria identified in this epidemic were from patients already admitted to the intensive care unit of 
the Sakarya University Training and Research Hospital during efforts toward establishment of infection surveillance 
and control program. Antimicrobial susceptibility testing of strains was performed using the VITEK 2 system (bioMé-
rieux, France), E-test gradient strips (bioMérieux, France), and the disc diffusion test. For the metallo-beta-lactamase 
activity, the combined disc diffusion test and modified Hodge test as phenotypic tests were performed. To identify 
the resistance gene, the Xpert Carba-R kit (Cepheid Inc., USA) and an in-house multiplex polymerase chain reaction 
(PCR) method designed for five common carbapenemase genes (IMP, VIM, KPC, NDM-1, and OXA-48) were employed. 
The clonal relationship of these strains was explored by the repetitive PCR (rep-PCR, DiversiLab System, bioMérieux, 
France) method.
Results: During the December 2014 to March 2015 period, NDM-1 positive K. pneumoniae strains were detected in 
eight patients. All of these strains were found to produce NDM-1, while two of them also revealed the presence of 
OXA‐48. The rep-PCR results reveal a clonal proximity of 95 % for six of the eight strains.
Conclusions: Our findings suggest the tendency of NDM-1-producing strains to spread in our country as well. A 
carbapenem-resistant K. pneumoniae threat may pose a great risk to our country. It is clear that more comprehensive 
infection control precautions should be implemented in our hospitals.
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Background
Beta-lactamase production is one of the most common 
defence mechanisms of gram-negative bacteria for resist-
ance against beta-lactam antibiotics [1]. The numbers of 
beta-lactamase enzymes are way more than 350. Over the 
years, numerous beta-lactamases and carbapenemases 
have been identified in gram-negative bacteria [2]. How-
ever, many centres have recently reported carbapene-
mase-producing gram-negative strains [3].
The treatment of carbapenemase-producing Entero-
bacteriaceae strains is very difficult. The most com-
mon mechanisms observed responsible for resistance 
against carbapenems in Klebsiella species may be listed 
as follows: production of particularly Klebsiella pneu-
moniae carbapenemase (KPC) in Ambler class A, met-
allo-beta-lactamases (MBLs) in class B (e.g. Verona 
integron-encoded metallo-beta-lactamase (VIM), 
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imipenem-hydrolyzing beta-lactamase (IMI/IMP)), and 
OXA enzymes in Class D (beta-lactamases that hydrolize 
oxacillin and cloxacillin e.g., OXA-48). MBLs, can be 
separated into those that are chromosomally originated 
and those that are encoded by transferable genes [4]. All 
MBLs, share extra useful characters including strong 
carbapenemase activity, resistance to clinical beta-lacta-
mase inhibitors (such as clavulanate), and lack of activity 
against monobactams [5].
Recently, production of New Delhi metallo‐β‐lac-
tamases (NDM) have been reported in Enterobac-
teriaceae, Acinetobacter spp. and Pseudomonas 
aeruginosa strains. NDM-producing bacteria can 
spread from human to human and from water sources, 
foods of animal origin, and also from the polluted 
environment. NDM-producing strains have given rise 
to a number of infections resistant against almost all 
beta-lactamases, aminoglycosides, quinolones, nitro-
furantoin, and sulphonamides. Moreover, in NDM-
producing strains, such resistance can readily spread, 
thanks to NDM-encoding multiple chromosomal and 
plasmid-origin resistance genes. The carbapenemase-
producing K. pneumoniae strain was first reported in 
North Carolina in 2001 [6]. Particularly over the last 
5 years, the increase in the number of KPC-produc-
ing isolates is noteworthy. Despite the fact that the 
NDM were first identified in India in 2008, today they 
appear in a widespread pattern in a myriad of coun-
tries worldwide, primarily India, Pakistan, the USA, 
and the Balkan states. In Turkey, different centres have 
reported NDM-producing K. pneumoniae strains [7]. 
MBLs notifications from Turkey have increased in 
recent years. In a study, Karaaslan et  al. studied 762 
hospitalized children. Of these, 176 (23 %) were colo-
nized with carbapenem resistant gram-negative bacilli 
(CR-GNB). NDM (31 %) was the second most frequent 
carbapenemase that was identified in Acinetobacter 
baumannii isolates. All of the 17 patients colonized 
with NDM-producing A. baumannii were newborns 
in the neonatal intensive care unit. Independent risk 
factors for CR-GNB colonization were: age  <1  year, 
nasogastric tube placement, presence of underlying 
chronic diseases, ampicillin or carbapenem usage, 
surgical intervention [8]. In  another study, Sahin 
and colleagues, examined 43 carbapenem-resistant 
strains  and detected OXA-48  gene in seven isolates 
and NDM-1 gene in one isolate [9]. These findings 
indicate that carbapenem resistance  due to the pro-
duction of NDM-1 carbapenemase is spreading in 
Turkey.
The aim of this article is to report the NDM-1 produc-
ing K. pneumoniae epidemic involving eight patients (two 
of which are also harbouring the OXA-48 gene).
Methods
Patients and bacteria strains
Sakarya University Hospital has a 900-bed capacity and a 
65-bed capacity in the intensive care unit. The Infection 
Control Committee (ICC) was established in our hospital 
in 2008. Daily regular infection surveillance studies were 
done by the ICC. The patients identified in this epidemic 
were patients already admitted to the Sakarya Training 
and Research Hospital intensive care unit. Eight K. pneu-
moniae strains were obtained from various clinical sam-
ples from the eight patients during the efforts to control 
the infection.
Bacterial identification and antibiotic susceptibility testing 
and investigation of carbapenemase production
Identification and antimicrobial susceptibility testing of 
bacteria isolated from the ICU patient samples were con-
ducted by using the VITEK 2 (bioMérieux, France) auto-
mated system and the disc diffusion test. K. pneumoniae 
strains exhibited resistance to carbapenems in VITEK  2 
system. Resistance to carbapenems was also confirmed by 
E-test gradient strips (bioMérieux, France). Disc diffusion 
tests were interpreted according to the EUCAST criteria 
[10].
All isolates were inoculated onto ertapenem (2  mg/L) 
screen medium. Carbapenemase production was veri-
fied phenotypically by the modified Hodge test, and 
metallo-beta-lactamase activity was studied with the 
combined commercial disc test (Mast Diagnostics, Mer-
seyside, UK). The modified Hodge test was performed 
according to the CLSI guideline using Escherichia coli 
ATCC 25922 and imipenem disk [11].
Investigation of carbapenemase genes
On the GeneXpert device, IMP1, VIM, NDM, KPC, and 
OXA-48 genes were studied with the Xpert Carba-R kit 
(Cepheid Inc., USA) as per the guidelines of the manu-
facturer. Identified resistance genes were verified with 
Fig. 1 Results of multiplex PCR-gel imaging on K. pneumoniae strains
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the multiplex PCR and gel imaging method. Additionally 
presence of NDM-1 genes in the strains were verified by 
multiplex-PCR (Fig. 1).
The five most common carbapenemase genes 
(blaOXA-48, blaNDM-1, blaIMP, blaVIM, and blaKPC) were 
investigated by an in-house multiplex PCR test. We used 
the primers which were previously described in the study 
by Poirel et  al. [12]. The DNA was extracted by boiling 
the strains at 95 °C for 5 min. The PCR mixture was con-
stituted of 4 μL master mix (5×  HOT FIREPol Blend 
Master Mix Ready to Load, Solis BioDyne, Estonia), 12 
μL dH2O, 1 μL primer mix (metabion GmBh, Germany), 
and 3 μL bacterial DNA (total volume 20 μL). The PCR 
protocol followed was 10 min at 94  °C denaturation; 35 
cycles of 30 s at 94  °C, 40 s at 56  °C, and 50 s at 72  °C; 
and final extension for 5 min at 72 °C. PCR products were 
dyed with SYBR gold, loaded into 2  % agarose gel, and 
run on an observable real time electrophoresis (ORTE) 
instrument (Salubris Technica, Istanbul).
Clonal relationship
Repetitive PCR
Repetitive PCR analyses were managed using the Diver-
siLab (DL) bacterial typing system, a semi-automated 
typing system based on repetitive extragenic palindromic 
sequence-based PCR (rep-PCR) (bioMérieux, France). 
The obtained DNA was quantified by spectrophotom-
etry with the Gene Quant 1300 (GE Healthcare Europe 
GmbH, Milan, Italy) and diluted to 25–50 ng/ml. Diluted 
DNA was amplified using the Klebsiella fingerprinting 
kit (bioMérieux, France) according to the manufactur-
er’s instructions. Amplicons were analyzed using a 2100 
Bioanalyzer (Agilent Technologies, USA). For this pro-
cedure, we used a microfluidics chip (LabChip device, 
Caliper Technologies Inc., Hopkinton, MA, USA) that 
separates DNA fragments of different sizes, resulting in 
chromatograms with peaks for each amplicon. Analy-
sis was performed by Internet-based DL software 3.4, 
which creates virtual gel images and uses the band-based 
modified Kullback–Leibler distance to calculate percent-
age similarities. The automatically generated dendro-
grams, similarity matrices, electropherograms, virtual gel 
images, scatter plots, and selectable demographic fields 
were used for interpretation.
DNA band patterns from the DL system were analyzed 
using the DL analysis software (bioMérieux, France) with 
the Pearson correlation coefficient to determine the dis-
tance matrices and the unweighted pair-wise grouping 
with mathematical averages (UPGMA) for similarities 
and cluster analysis, respectively. Homologies of >97  % 
and 95–97  % were regarded as the parent clone (indis-
tinguishable) and similar isolates, respectively, accord-
ing to the manufacturer’s recommendations and results 
of longitudinal studies and comparisons [13]. A similarity 
value <95 % was considered to indicate a difference [14]. 
In addition, as in some studies, the DL system cut-off 
value was assumed as 90 % for K. pneumoniae strains for 
this assessment [15].
Infection control protocols
Aggressive infection control screening protocols and 
laboratory testing measures were in place to identify 
cases. All positive patients and ICU staff members were 
screened for K. pneumoniae NDM-1 and a follow-up 
screening was conducted on a weekly basis. Antibiotic 
usage was reviewed. Positive patients were selected and 
isolated from negative patients. Infection control proce-
dures in healthcare facilities, such as proper instrument 
and hard-surface disinfection, and a strict adherence to 
hand hygiene were implemented. Routine rectal swab 
cultures were obtained from all patients before ICU 
acceptance during the epidemic.
Results
It was found that the first NDM positive (+) case was 
imported from a hospital located 50 km away from our 
hospital, with subsequent incoming patients clustering 
in January 2015. In this study, eight NDM-1 positive K. 
pneumoniae strains isolated from different clinical sam-
ples of eight patients were examined between December 
2014 and March 2015. All of the patients were already 
intensive care patients of our hospital. All bacteria 
strains, except for a wound and a central catheter sam-
ple, were isolated from blood cultures. All of the patients 
with NDM-1-producing isolates in the blood culture 
ended up dying, except one patient in which NDM-1 (+) 
K. pneumoniae was isolated from his wound sample and 
who was discharged with a full recovery. The demograph-
ics and clinical facts of the patients are summarized in 
Table  1. Seven NDM-1 positive patients with Klebsiella 
bacteremia died (88 % mortality rate).
We have studied the susceptibility of isolated NDM-1 
(+) strains to antibiotics as potential treatment alterna-
tives, such as amikacin, gentamicin, ciprofloxacin, colis-
tin, and tigecycline, and found no strain susceptible to 
these antibiotics.
In the K. pneumoniae strains isolated from various 
clinical samples from the eight patients, the same results 
were obtained both with the Xpert Carba-R kit on the 
GeneXpert device and with the multiplex PCR gel imag-
ing method. All NDM positive isolates were also found 
positive with Xpert Carba-R kit on the GeneXpert. The 
enzyme genes found are presented in Table  1. The rep-
PCR (DL System) results reveal a clonal proximity of 
95–100  % for six of the eight strains all except for the 
strains isolated from the samples of patients 6 and 7. In 
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other words, the six strains are clonally indistinguishable. 
Since the two strains from patients 6 and 8 reveal a simi-
larity of less than 80 %, they were found to have no clonal 
proximity with the others. The DL system has revealed 
an overall clonal similarity rate of 87.2  % for all strains 
(Fig. 2).
Discussion
Some carbapenemases are reported to be more frequent 
in some regions. For example, while KPC-type beta-lac-
tamases are dominant in some countries such as Greece, 
Israel, and USA, NDM beta-lactamases are prevalent in 
isolates reported from the Far East, India, and Pakistan 
[16]. Carbapenemase production in Turkey mostly occurs 
in OXA type beta-lactamases [17]. OXA-48 was reported 
first from Turkey, subsequently followed by reports from 
Middle Asia and Europe as well [18]. These isolates gen-
erally lead to multiple resistance, therefore offering very 
limited treatment options.
To the best of our knowledge, this study is the fourth 
to identify the Turkey-originating NDM existence. How-
ever, the epidemic under this study is the high scale epi-
demic occurring in our country with strains carrying a 
co-existence of OXA-48 and NDM-1. Our findings sug-
gest the tendency of NDM-producing strains to spread 
in our country as well. As a matter of fact, six of the K. 
pneumoniae strains in the epidemic breaking out in our 
hospital were found to be clonally indistinguishable. 
These strains are likely to be emerging and spreading 
from the hospital. Therefore, the fact that such bacteria 
may easily spread among inpatients of the same hospital 
and during transfers to different medical centers should 
strictly be considered.
Resistance occurring with similar strains was also 
reported from Saudi Arabia and other Middle Eastern 
countries. Strains excreting NDM have the potential to 
rapidly spread within the country and to other coun-
tries. In a study, carbapenem non-susceptible Enterobac-
teriaceae in the Arabian Peninsula were investigated in 
200 isolates collected from 16 hospitals in Saudi Arabia, 
Kuwait, Oman and the United Arab Emirates. In the col-
lection, NDM-1 was the most frequently encountered 
carbapenemase gene (46.5  %) in their study [19]. Tur-
key is recently and increasingly benefiting from medical 
tourism. In particular, some hospitals in Istanbul admit 
a great number of patients, and such resistance emerging 
from patients admitted to the intensive care units of such 
hospitals is easily spreading throughout Turkey. Moreo-
ver, thousands of medical tourists come to Turkey from 
different parts of the world. If we cannot stop this epi-
demic, it will easily spread to different countries.
Bacteremia caused by such strains culminates in a high 
fatality rate. Given the fact that all of our cases that devel-
oped bacteraemia have died, the criticality of the threat 
we face can better be understood. Besides, there is unfor-
tunately no antibiotic offering an effective treatment 
against infections caused by bacteria with this resistance 
mechanism.
It is probable that such resistance could spread to 
many centers throughout the country and throughout 
the world. It was also reported from Turkey that OXA-48 
and beyond were found in Klebsiella pneumoniae isolates 
Table 1 Demographic, clinical, and laboratory data of patients
CR carbapenem resistant, F female, M male







External centre Isolated from NDM/
NDM + OXA
Result
1 59 F Chronic renal fail-
ure, diabetes
10.05.2014 29.12.2014 No Blood NDM Dead
2 53 F Over carcinoma 10.05.2014 15.01.2015 No Blood NDM Dead
3 67 F Chronic renal fail-
ure, diabetes
09.09.2014 03.01.2015 Istanbul Private 
Hospital
Blood NDM + OXA-48 Dead
4 74 F Cerebrovascular 
disease
24.09.2014 08.01.2015 Kocaeli University 
Hospital
Blood NDM Dead
5 88 M Hip fracture 08.10.2014 30.12.2014 Istanbul Iklim 
Private Hospital
Central catheter NDM Dead
6 28 M Cervical fracture 15.12.2014 05.01.2015 Sakarya Adatip 
Hospital
Blood NDM Dead
7 76 F Cerebrovascular 
disease, alzhei-
mer
15.12.2014 15.01.2015 Haydarpaşa Train-
ing Hospital/
Istanbul
Wound NDM + OXA-48 Alive
8 56 F Hypertension 
and fournier 
gangrene
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nearly one decade ago [20]. Based on the results of this 
study, a combination of both OXA-48 and NDM-1 type 
resistance could easily spread. This situation can cause 
significant morbidity. Therefore, the presence of NDM 
and OXA-48 in carbapenem-resistant K. pneumoniae 
strains isolated from patients in the intensive care units 
in Turkey should be explored. Moreover, our hospitals 
should create awareness about this type of resistance, and 
measures to prevent the resistance from spreading should 
be done immediately. A forceful infection control and 
prevention strategy should be implemented, and should 
contain the reinforcement of hand hygiene, contact pre-
cautions, and initial recognition of CRE through the use 
of direct surveillance. We could not sequence typing of 
NDM producing K. pneumoniae due to project budget.
Conclusions
The bacteremia mediated by NDM-1-producing K. 
pneumoniae was observed for the first time in India in 
2008, and strains with the same resistance mechanism 
could spread up to Turkey and may likely spread to 
many other countries therefrom. Moreover, we found 
that the NDM-1 resistance of K. pneumoniae isolates 
also can be accompanied by OXA-48. For this agent 
with limited treatment options, we should comply with 
measures for controlling infection. We believe that the 
treatment of infectious diseases in the intensive care 
units of our country could be much harder in the com-
ing years.
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